JNJ

Joaquin Duato

Known title: CEOCIK: 0001673401

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Johnson & Johnson: Key Takeaways for Long-Term Investors. Recent coverage highlighted three takeaways for long‑term investors in Johnson & Johnson. The article notes the company's steady dividend yield of about 3.1% and its diversified healthcare portfolio. It also points to a relatively high price‑to‑earnings multiple, suggesting expectations of continued growth. These points are relevant as the stock trades near a long‑standing support level.

this person other insiders at JNJ

Transaction History

JNJ▲ Buy$14.3M
JNJ▼ Sell$5.5M
JNJ▼ Sell$26.7M
JNJ▼ Sell$10.8M
JNJ▼ Sell$1.7M
JNJ▲ Buy$0
JNJ▼ Sell$390K
JNJ▲ Buy$0
JNJ▼ Sell$477K
JNJ▲ Buy$0
JNJ▼ Sell$242K
JNJ▲ Buy$0
JNJ▼ Sell$7.7M
JNJ▼ Sell$11.3M
JNJ▼ Sell$10.8M
JNJ▲ Buy$12.8M
JNJ▼ Sell$22.5M
JNJ▼ Sell$0
JNJ▼ Sell$0
JNJ▼ Sell$250K
JNJ▲ Buy$0
JNJ▼ Sell$234K
JNJ▲ Buy$0
JNJ▼ Sell$344K
JNJ▲ Buy$0
JNJ▼ Sell$1.3M
JNJ▲ Buy$0
JNJ▼ Sell$15.4M
JNJ▲ Buy$12.6M
JNJ▲ Buy$0
JNJ▼ Sell$238K
JNJ▲ Buy$0
JNJ▲ Buy$0
JNJ▼ Sell$2.5M
JNJ▲ Buy$11.8M
JNJ▼ Sell$15.5M
JNJ▲ Buy$0
JNJ▼ Sell$355K
JNJ▼ Sell$0
JNJ▲ Buy$0
JNJ▼ Sell$2.2M
JNJ▲ Buy$0
JNJ▼ Sell$367K
JNJ▲ Buy$10.8M
JNJ▼ Sell$17.1M
JNJ▲ Buy$0
JNJ▼ Sell$2.1M
JNJ▲ Buy$0
JNJ▼ Sell$398K
JNJ▲ Buy$5.5M
JNJ▼ Sell$9.1M

We use analytics to understand how market-wall is used. No personal data is sold.